EPO Patents = 5

Forward Citations = 2

Loading Chart...

19 inventors (with patents filed for the assignee):

Richard L Mackman (4 out of 94 patents)

Petr Jansa (4 out of 27 patents)

Caroline Aciro (4 out of 9 patents)

4. David Kenneth Dean (4 out of 9 patents)

5. Adrian John Highton (4 out of 8 patents)

6. Andrew John Keats (4 out of 11 patents)

7. Linos Lazarides (4 out of 18 patents)

8. Karine G Poullennec (4 out of 11 patents)

9. Victoria Alexandra Steadman (4 out of 16 patents)

10. Adam James Schrier (4 out of 23 patents)

11. Dustin S Siegel (4 out of 57 patents)

12. Neil Andrew Dunbar (3 out of 6 patents)

13. Simon Neil Pettit (3 out of 23 patents)

14. Kapil Kumar Karki (3 out of 13 patents)

15. Rhonan Lee Ford (2 out of 4 patents)

6 patents: Sort by Forward Citations

1. 10472392 - Macrocyclic inhibitors of flaviviridae viruses (2019-11-12),

2. RE47334 - Macrocyclic inhibitors of flaviviridae viruses (2019-04-01),

3. 10246486 - Macrocyclic inhibitors of flaviviridae viruses (2019-04-02),

4. 9895412 - Cyclic depsipeptide compounds and their uses (2018-02-20),

5. 9873716 - Macrocyclic inhibitors of flaviviridae viruses (2018-01-23),

6. 9382295 - Cyclic depsipeptide compounds and their uses (2016-07-05),

Cypralis is a leading biotechnology company focused on the discovery and development of novel therapeutics for the treatment of serious diseases. With a focus on targeting protein misfolding diseases, Cypralis is developing a pipeline of small molecule drugs with the potential to address significant unmet medical needs. Through strategic partnerships and collaborations, Cypralis aims to bring innovative therapies to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#130 in Cambridge

#2,628 in United Kingdom

Cambridge, United Kingdom

Cypralis Limited